Enjoy complimentary customisation on priority with our Enterprise License!
The global needle-free drug delivery devices market has the potential to grow by USD 10.23 billion during 2020-2024 and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.
This report provides a detailed analysis of the market by product (inhalers, transdermal patches, and jet injectors) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.
Browse TOC and LoE with selected illustrations and example pages of needle-free drug delivery devices market
The needle-free drug delivery devices market is currently fragmented, and the degree of fragmentation will decrease during the forecast period. Market vendors are focusing on strategic alliances and launching new products to expand their geographical reach and strengthen their position in the needle-free drug delivery devices market. 3M Co., Antares Pharma Inc., and Becton are some of the major market participants. Although the growing prevalence of chronic diseases will offer immense growth opportunities, the high costs associated with needle-free drug delivery devices will challenge the growth of the market participants. To increase their needle-free drug delivery devices market share, companies should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this needle-free drug delivery devices market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this needle-free drug delivery devices market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading needle-free drug delivery device companies, including:
For more insights on the market share of various regions Request for a FREE sample now!
North America was the largest market for needle-free drug delivery devices in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Increasing prevalence of chronic conditions, the development of advanced products, and rising partnerships by vendors are some of the significant factors responsible for needle-free drug delivery devices market growth in this region.
Over 39% of the market’s growth will originate from North America during the forecast period. The US is an essential market for needle-free drug delivery devices in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.
Request for a FREE sample and get more information on the market contribution of various product segments
Inhalers are portable and lightweight and can deliver medications to the airways immediately. The high incidence of asthma and the rising awareness about inhalers are some of the factors driving the growth of the needle-free drug delivery devices market in this segment.
Market growth in this segment will be slower than the growth of the market in the transdermal patches and jet injectors segments. This report provides an accurate prediction of the contribution of all the segments to the growth of the needle-free drug delivery devices market size.
The increasing prevalence of chronic diseases will be a significant factor in driving the growth of the needle-free drug delivery devices market. There is a growing prevalence of various chronic diseases such as diabetes and asthma. The demand for needle-free drug delivery devices will especially increase due to the high incidence of type 1 diabetes in children who require regular administration of insulin. Growing pollution and respiratory infections have also contributed to the rising rates of asthma. Needle-free drug delivery devices are widely used for the treatment of asthma as it helps in the immediate administration of asthmatic medications. With the increasing prevalence of chronic diseases, the demand for needle-free drug delivery devices will also grow.
Request for a FREE sample now!
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.